Virtual Conference
Life Science Technical Accounting Update 2026
- Dates
- Sept 16-17, 2026
- CPE Credits
- 16
- Location
- Virtual (PT)
- Field of Study
- lifesci
Early bird: $545 (through 8/26/2026) · List: $695
Register Now →The life science industry continues to face rapid change—new ASUs, evolving revenue models, digital transformation, and increasingly complex reporting expectations. The Life Science Technical Accounting Update 2026 is a two-day 16 CPE virtual conference designed to help finance and accounting teams stay ahead of these developments with guidance tailored specifically to biotech, pharma, and med-tech companies.
This program goes beyond the standards to focus on real-world application. Sessions will cover select ASUs, practical uses of AI and digital transformation in accounting operations, and the most challenging revenue recognition issues facing life science organizations
LEARNING OBJECTIVES:
- Understand the latest accounting updates and ASUs most relevant to life science companies
- Identify key timelines, implementation considerations, and factors influencing industry-specific reporting
- Gain practical insight into applying AI and digital solutions within life science accounting and finance functions
Schedule
Agenda: DAY 1
| Time | Session |
|---|---|
| 8:45–10:10 | Life Science Industry Overview Sector Landscape Miodalities and development pathway Business models and capital formation CFO, accounting and tax lens Regulatory and reinforcement Strategic trends Governance and risk |
| 10:10–10:30 | Break |
| 10:30–12:00 | Gross to Net & Inventory Accounting Gross to Net Introduction and Overview Industry View Estimation Methodology Approaching Launch Key Challenges SEC Comments Close and Financial Reporting GTN Hot Topics Discussion Inventory Accounting Refresh |
| 12:00–12:45 | Lunch Break |
| 1:2:45–2:05 | Revenue Recognition for Collaboration & License Agreements Analyze key 606 considerations Understand disclosure expectations Practical approached for estimating and constraining variable consideration Review real-world examples |
| 2:05–2:15 | Break |
| 2:15–3:30 | GenAI Automation Update What works and what doesn’t in corporate accounting Understanding the AI spectrum and AI agents AI in financial reporting & demo Potential impacts to your audit |
| 3:30–3:40 | Break |
| 3:40–5:00 | Budgeting and Forecasting Best Practices Real life examples of successes and failures Forecast models Leverage different technology approaches |
Agenda: DAY 2
| Time | Session |
|---|---|
| 8:45–9:55 | Tax Update Latest legislative developments Key Tax Proposals Possible timing and other legislative priorities |
| 9:55–10:10 | Break |
| 10:10–11:30 | Accounting for Financing Arrangements in Life Sciences |
| 11:30–11:45 | Break |
| 11:45–1:10 | Accounting for R&D and Clinical Trials R&D Funding Arrangements R&D Cost Classifications Other Intangible Assets SEC Comment Letter Trends |
| 1:10–2:00 | Lunch Break |
| 2:00–3:15 | SEC & FASB Developments Affecting Life Science Companies Disaggregation of income statement expenses Improvements to income tax disclosures SEC Comment Letter trends FASB developments US regulatory updates PCAOB standard-setting and rulemaking activity |
| 3:15–3:30 | Break |
| 3:30–4:50 | SOX & Internal Controls Update Use of Gen AI Segment Reporting Control Considerations Risk Assessment refresh Deficiencies and severity assessment |